Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation
Open Access
- 31 August 2024
- journal article
- research article
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 64 (8) , 56-63
Abstract
Aim . Atrial fibrillation (AF) is a rhythm disorder characterized by very rapid and disorganized atrial-derived electrical activations with uncoordinated atrial contractions. Very short periods of AF-like activity (micro-AF) may be precursors of undetected, silent episodes of atrial fibrillation. Here, we examined the relationship between natriuretic peptide concentrations and echocardiography findings in patients with micro-AF. Material and methods . The electrocardiograms (ECGs) of patients complaining of palpitations were recorded with a 24‑hour Holter monitor, and the patients were consecutively included in the study. Micro-AF was defined as sudden, irregular atrial tachycardia lasting less than 30 sec with episodes of ≥5 consecutive supraventricular depolarizations with the absolute absence of p-waves. After a G-power test, patients were consecutively included in the study: 45 patients in the micro-AF group and 45 patients in the control group. Laboratory parameters, ECG and echocardiographic findings of the two groups were compared. Results . N-terminal pro B-type natriuretic peptide (Pro-BNP) and serum troponin T concentrations were higher in the micro-AF group, (375.5±63.6 pg / ml vs. 63.1±56.8 pg / ml, pConclusions . Micro-AF in patients may be predicted by evaluating ECG, echocardiographic, and serum natriuretic peptide data.Keywords
This publication has 23 references indexed in Scilit:
- Left Volume Atrial Index and P-wave Dispersion as Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft: A Retrospective Cohort StudyCurrent Problems in Cardiology, 2023
- Prognostic Impact of Echocardiographic Congestion Grade in HFpEF With and Without Atrial FibrillationJACC: Asia, 2022
- Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trialThe Lancet, 2021
- Atrial and brain natriuretic peptides: Hormones secreted from the heartPeptides, 2019
- Racial and ethnic differences in atrial fibrillation risk factors and predictors in women: Findings from the Women's Health InitiativeAmerican Heart Journal, 2016
- Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic PatientsJACC: Heart Failure, 2013
- Guidelines for the management of atrial fibrillationEP Europace, 2010
- Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillationJACC, 2005
- P Wave Dispersion on 12‐Lead Electrocardiography in Patients with Paroxysmal Atrial FibrillationPacing and Clinical Electrophysiology, 2000
- Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArchives of internal medicine (1960), 1995